62 related articles for article (PubMed ID: 17083342)
1. Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study.
Bosch F; Cantin G; Cortelezzi A; Knauf W; Tiab M; Turgut M; Zaritskey A; Merot JL; Tausch E; Trunzer K; Robson S; Gresko E; Böttcher S; Foà R; Stilgenbauer S; Leblond V
Leukemia; 2020 Feb; 34(2):441-450. PubMed ID: 31455851
[TBL] [Abstract][Full Text] [Related]
2. Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia.
Gassner FJ; Weiss L; Geisberger R; Hofbauer JP; Egle A; Hartmann TN; Greil R; Tinhofer I
Cancer Immunol Immunother; 2011 Jan; 60(1):75-85. PubMed ID: 20857100
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for high-risk chronic lymphocytic leukaemia.
Hewamana S; Dearden C
Ther Adv Hematol; 2011 Jun; 2(3):147-59. PubMed ID: 23556086
[TBL] [Abstract][Full Text] [Related]
4. The toxic effect on leukocyte lineage of antimicrobial therapy in urinary and respiratory infections.
Junuzovic D; Zunic L; Dervisefendic M; Skopljak A; Pasagic A; Masic I
Med Arch; 2014 Jun; 68(3):167-9. PubMed ID: 25568526
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in critically ill chronic lymphocytic leukemia patients.
Xhaard A; Epelboin L; Schnell D; Vincent F; Levy V; Malphettes M; Azoulay E; Darmon M
Support Care Cancer; 2013 Jul; 21(7):1885-91. PubMed ID: 23411999
[TBL] [Abstract][Full Text] [Related]
6. Treatment of older patients with chronic lymphocytic leukemia.
Lamanna N
Curr Hematol Malig Rep; 2012 Mar; 7(1):21-5. PubMed ID: 22234621
[TBL] [Abstract][Full Text] [Related]
7. Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia.
Janssens A; Boogaerts M; Verhoef G
Drug Des Devel Ther; 2009 Dec; 3():241-52. PubMed ID: 20054443
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
Hallek M; Cheson BD; Catovsky D; Caligaris-Cappio F; Dighiero G; Döhner H; Hillmen P; Keating MJ; Montserrat E; Rai KR; Kipps TJ;
Blood; 2008 Jun; 111(12):5446-56. PubMed ID: 18216293
[TBL] [Abstract][Full Text] [Related]
9. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
10. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
[TBL] [Abstract][Full Text] [Related]
11. Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.
Eichhorst BF; Busch R; Schweighofer C; Wendtner CM; Emmerich B; Hallek M;
Br J Haematol; 2007 Jan; 136(1):63-72. PubMed ID: 17083342
[TBL] [Abstract][Full Text] [Related]
12. Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.
Flinn IW; Neuberg DS; Grever MR; Dewald GW; Bennett JM; Paietta EM; Hussein MA; Appelbaum FR; Larson RA; Moore DF; Tallman MS
J Clin Oncol; 2007 Mar; 25(7):793-8. PubMed ID: 17283364
[TBL] [Abstract][Full Text] [Related]
13. Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy.
Marotta G; Bigazzi C; Lenoci M; Tozzi M; Bocchia M; Lauria F
Haematologica; 2000 Dec; 85(12):1268-70. PubMed ID: 11114133
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group.
Eichhorst BF; Busch R; Obwandner T; Kuhn-Hallek I; Herschbach P; Hallek M;
J Clin Oncol; 2007 May; 25(13):1722-31. PubMed ID: 17389338
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
